Cargando…

Immunomodulatory effect of hypertonic saline in hemorrhagic shock

Multiple organ dysfunction syndrome (MODS) and nosocomial infection following trauma-hemorrhage are among the most important causes of mortality in hemorrhagic shock patients. Dysregulation of the immune system plays a central role in MODS and a fluid having an immunomodulatory effect could be advan...

Descripción completa

Detalles Bibliográficos
Autores principales: Motaharinia, Javad, Etezadi, Farhad, Moghaddas, Azadeh, Mojtahedzadeh, Mojtaba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593217/
https://www.ncbi.nlm.nih.gov/pubmed/26437974
http://dx.doi.org/10.1186/s40199-015-0130-9
_version_ 1782393296745660416
author Motaharinia, Javad
Etezadi, Farhad
Moghaddas, Azadeh
Mojtahedzadeh, Mojtaba
author_facet Motaharinia, Javad
Etezadi, Farhad
Moghaddas, Azadeh
Mojtahedzadeh, Mojtaba
author_sort Motaharinia, Javad
collection PubMed
description Multiple organ dysfunction syndrome (MODS) and nosocomial infection following trauma-hemorrhage are among the most important causes of mortality in hemorrhagic shock patients. Dysregulation of the immune system plays a central role in MODS and a fluid having an immunomodulatory effect could be advantageous in hemorrhagic shock resuscitation. Hypertonic saline (HS) is widely used as a resuscitation fluid in trauma-hemorrhagic patients. Besides having beneficial effects on the hemodynamic parameters, HS has modulatory effects on various functions of immune cells such as degranulation, adhesion molecules and cytokines expression, as well as reactive oxygen species production. This article reviews clinical evidence for decreased organ failure and mortality in hemorrhagic shock patients resuscitated with HS. Despite promising results in animal models, results from pre-hospital and emergency department administration in human studies did not show improvement in survival, organ failure, or a reduction in nosocomial infection by HS resuscitation. Further post hoc analysis showed some benefit from HS resuscitation for severely-injured patients, those who received more than ten units of blood by transfusion, patients who underwent surgery, and victims of traumatic brain injury. Several reasons are suggested to explain the differences between clinical and animal models.
format Online
Article
Text
id pubmed-4593217
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45932172015-10-06 Immunomodulatory effect of hypertonic saline in hemorrhagic shock Motaharinia, Javad Etezadi, Farhad Moghaddas, Azadeh Mojtahedzadeh, Mojtaba Daru Review Article Multiple organ dysfunction syndrome (MODS) and nosocomial infection following trauma-hemorrhage are among the most important causes of mortality in hemorrhagic shock patients. Dysregulation of the immune system plays a central role in MODS and a fluid having an immunomodulatory effect could be advantageous in hemorrhagic shock resuscitation. Hypertonic saline (HS) is widely used as a resuscitation fluid in trauma-hemorrhagic patients. Besides having beneficial effects on the hemodynamic parameters, HS has modulatory effects on various functions of immune cells such as degranulation, adhesion molecules and cytokines expression, as well as reactive oxygen species production. This article reviews clinical evidence for decreased organ failure and mortality in hemorrhagic shock patients resuscitated with HS. Despite promising results in animal models, results from pre-hospital and emergency department administration in human studies did not show improvement in survival, organ failure, or a reduction in nosocomial infection by HS resuscitation. Further post hoc analysis showed some benefit from HS resuscitation for severely-injured patients, those who received more than ten units of blood by transfusion, patients who underwent surgery, and victims of traumatic brain injury. Several reasons are suggested to explain the differences between clinical and animal models. BioMed Central 2015-10-05 /pmc/articles/PMC4593217/ /pubmed/26437974 http://dx.doi.org/10.1186/s40199-015-0130-9 Text en © Motaharinia et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review Article
Motaharinia, Javad
Etezadi, Farhad
Moghaddas, Azadeh
Mojtahedzadeh, Mojtaba
Immunomodulatory effect of hypertonic saline in hemorrhagic shock
title Immunomodulatory effect of hypertonic saline in hemorrhagic shock
title_full Immunomodulatory effect of hypertonic saline in hemorrhagic shock
title_fullStr Immunomodulatory effect of hypertonic saline in hemorrhagic shock
title_full_unstemmed Immunomodulatory effect of hypertonic saline in hemorrhagic shock
title_short Immunomodulatory effect of hypertonic saline in hemorrhagic shock
title_sort immunomodulatory effect of hypertonic saline in hemorrhagic shock
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593217/
https://www.ncbi.nlm.nih.gov/pubmed/26437974
http://dx.doi.org/10.1186/s40199-015-0130-9
work_keys_str_mv AT motahariniajavad immunomodulatoryeffectofhypertonicsalineinhemorrhagicshock
AT etezadifarhad immunomodulatoryeffectofhypertonicsalineinhemorrhagicshock
AT moghaddasazadeh immunomodulatoryeffectofhypertonicsalineinhemorrhagicshock
AT mojtahedzadehmojtaba immunomodulatoryeffectofhypertonicsalineinhemorrhagicshock